aDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, School of Medicine, San Francisco, CA;

bDepartment of Epidemiology and Biostatistics, University of California, School of Medicine, San Francisco, CA;

cUniversity of California, School of Medicine, Clinical Informatics, San Francisco, CA;

dSan Francisco Department of Public Health, San Francisco, CA;

eDepartment of Laboratory Medicine, University of California, School of Medicine, San Francisco, CA;

fDivision of Cardiovascular Medicine, Department of Medicine, University of Miami, School of Medicine, Miami, FL; and

gDivision of Cardiology, Department of Medicine, University of California, School of Medicine, San Francisco, CA.

Correspondence to: Elise Riley, PhD, Division of HIV, Infectious Disease and Global Medicine, UCSF Department of Medicine, Box 1272 UCSF Pride Hall, 2540 23rd Street, Floor 4, Rm 4212 San Francisco, CA 94143 (e-mail: [email protected]).

The authors have no funding or conflicts of interest to disclose.

Supported by the National Institute on Drug Abuse (R01 DA037012 and K24 DA039780).